A role for Tac2, NkB, and Nk3 receptor in normal and dysregulated fear memory consolidation

Neuron

Volumn 83, Issue 2, 2014, Pages 444-454

  Andero, Raül ^a,b   Dias, Brian G ^a,b   Ressler, Kerry J ^a,b,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Georgia State University   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II ALPHA; GLUTAMATE DECARBOXYLASE 65; NEUROKININ 3 RECEPTOR; NEUROKININ B; TACHYKININ 2; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; EMOTIONALITY; ENZYME LOCALIZATION; FEAR; GENE; GENE EXPRESSION; GENE FUNCTION; GENE LOCATION; MALE; MEMORY CONSOLIDATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TAC2 GENE;

AMYGDALA; ANIMALS; CONDITIONING, CLASSICAL; FEAR; MALE; MEMORY; MICE; NEUROKININ B; NEURONS; PIPERIDINES; PROTEIN PRECURSORS; RECEPTORS, NEUROKININ-3; TACHYKININS;

EID: 84904381874     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2014.05.028     Document Type: Article

References (49)

1. Almli L.M., Mercer K.B., Kerley K., Feng H., Bradley B., Conneely K.N., Ressler K.J. ADCYAP1R1 genotype associates with post-traumatic stress symptoms in highly traumatized African-American females. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2013, 162B:262-272.
2. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM5) 2013, American Psychiatric Association, American Psychiatric Publishing, Washington, DC.
3. Andero R., Ressler K.J. Fear extinction and BDNF: translating animal models of PTSD to the clinic. Genes Brain Behav. 2012, 11:503-512.
4. Andero R., Heldt S.A., Ye K., Liu X., Armario A., Ressler K.J. Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning. Am. J. Psychiatry 2011, 168:163-172.
5. Andero R., Brothers S.P., Jovanovic T., Chen Y.T., Salah-Uddin H., Cameron M., Bannister T.D., Almli L., Stevens J.S., Bradley B., et al. Amygdala-dependent fear is regulated by Oprl1 in mice and humans with PTSD. Sci. Transl. Med. 2013, 5:88ra73.
6. Armario A., Escorihuela R.M., Nadal R. Long-term neuroendocrine and behavioural effects of a single exposure to stress in adult animals. Neurosci. Biobehav. Rev. 2008, 32:1121-1135.
7. Beaujouan J.C., Torrens Y., Saffroy M., Kemel M.L., Glowinski J. A 25 year adventure in the field of tachykinins. Peptides 2004, 25:339-357.
8. Bergado-Acosta J.R., Sangha S., Narayanan R.T., Obata K., Pape H.C., Stork O. Critical role of the 65-kDa isoform of glutamic acid decarboxylase in consolidation and generalization of Pavlovian fear memory. Learn. Mem. 2008, 15:163-171.
9. Cho J.H., Zushida K., Shumyatsky G.P., Carlezon W.A., Meloni E.G., Bolshakov V.Y. Pituitary adenylate cyclase-activating polypeptide induces postsynaptically expressed potentiation in the intra-amygdala circuit. J.Neurosci. 2012, 32:14165-14177.
10. Ciocchi S., Herry C., Grenier F., Wolff S.B., Letzkus J.J., Vlachos I., Ehrlich I., Sprengel R., Deisseroth K., Stadler M.B., et al. Encoding of conditioned fear in central amygdala inhibitory circuits. Nature 2010, 468:277-282.
11. de Souza Silva M.A., Lenz B., Rotter A., Biermann T., Peters O., Ramirez A., Jessen F., Maier W., Hüll M., Schröder J., et al. Neurokinin3 receptor as a target to predict and improve learning and memory in the aged organism. Proc. Natl. Acad. Sci. USA 2013, 110:15097-15102.
12. Duarte C.R., Schütz B., Zimmer A. Incongruent pattern of neurokinin B expression in rat and mouse brains. Cell Tissue Res. 2006, 323:43-51.
13. Dunlop B.W., Mansson E., Gerardi M. Pharmacological innovations for posttraumatic stress disorder and medication- enhanced psychotherapy. Curr. Pharm. Des. 2012, 18:5645-5658.
14. Ebner K., Sartori S.B., Singewald N. Tachykinin receptors as therapeutic targets in stress-related disorders. Curr. Pharm. Des. 2009, 15:1647-1674.
15. Gallopin T., Geoffroy H., Rossier J., Lambolez B. Cortical sources of CRF, NKB, and CCK and their effects on pyramidal cells in the neocortex. Cereb. Cortex 2006, 16:1440-1452.
16. Gether U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr. Rev. 2000, 21:90-113.
17. Hashimoto H., Shintani N., Tanida M., Hayata A., Hashimoto R., Baba A. PACAP is implicated in the stress axes. Curr. Pharm. Des. 2011, 17:985-989.
18. Haubensak W., Kunwar P.S., Cai H., Ciocchi S., Wall N.R., Ponnusamy R., Biag J., Dong H.W., Deisseroth K., Callaway E.M., et al. Genetic dissection of an amygdala microcircuit that gates conditioned fear. Nature 2010, 468:270-276.
19. Hetrick S.E., Purcell R., Garner B., Parslow R. Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD). Cochrane Database Syst. Rev. 2010, CD007316.
20. Huang X., Hartley A.V., Yin Y., Herskowitz J.H., Lah J.J., Ressler K.J. AAV2 production with optimized N/P ratio and PEI-mediated transfection results in low toxicity and high titer for invitro and invivo applications. J.Virol. Methods 2013, 193:270-277.
21. Jasnow A.M., Ehrlich D.E., Choi D.C., Dabrowska J., Bowers M.E., McCullough K.M., Rainnie D.G., Ressler K.J. Thy1-expressing neurons in the basolateral amygdala may mediate fear inhibition. J.Neurosci. 2013, 33:10396-10404.
22. Kalló I., Vida B., Deli L., Molnár C.S., Hrabovszky E., Caraty A., Ciofi P., Coen C.W., Liposits Z. Co-localisation of kisspeptin with galanin or neurokinin B in afferents to mouse GnRH neurones. J.Neuroendocrinol. 2012, 24:464-476.
23. Kearns M.C., Ressler K.J., Zatzick D., Rothbaum B.O. Early interventions for PTSD: a review. Depress. Anxiety 2012, 29:833-842.
24. Khawaja A.M., Rogers D.F. Tachykinins: receptor to effector. Int. J. Biochem. Cell Biol. 1996, 28:721-738.
25. Krashes M.J., Koda S., Ye C., Rogan S.C., Adams A.C., Cusher D.S., Maratos-Flier E., Roth B.L., Lowell B.B. Rapid, reversible activation of AgRP neurons drives feeding behavior in mice. J.Clin. Invest. 2011, 121:1424-1428.
26. Lepicard E.M., Mizuno K., Antunes-Martins A., von Hertzen L.S., Giese K.P. An endogenous inhibitor of calcium/calmodulin-dependent kinase II is up-regulated during consolidation of fear memory. Eur. J. Neurosci. 2006, 23:3063-3070.
27. Lindefors N., Brodin E., Theodorsson-Norheim E., Ungerstedt U. Calcium-dependent potassium-stimulated release of neurokinin A and neurokinin B from rat brain regions invitro. Neuropeptides 1985, 6:453-461.
28. Mar L., Yang F.C., Ma Q. Genetic marking and characterization of Tac2-expressing neurons in the central and peripheral nervous system. Mol. Brain 2012, 5:3.
29. Meltzer H.Y., Arvanitis L., Bauer D., Rein W. Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder. Am. J. Psychiatry 2004, 161:975-984. Meta-Trial Study Group.
30. Mileusnic D., Lee J.M., Magnuson D.J., Hejna M.J., Krause J.E., Lorens J.B., Lorens S.A. Neurokinin-3 receptor distribution in rat and human brain: an immunohistochemical study. Neuroscience 1999, 89:1269-1290.
31. Mou L., Heldt S.A., Ressler K.J. Rapid brain-derived neurotrophic factor-dependent sequestration of amygdala and hippocampal GABA(A) receptors via different tyrosine receptor kinase B-mediated phosphorylation pathways. Neuroscience 2011, 176:72-85.
32. Nagano M., Saitow F., Haneda E., Konishi S., Hayashi M., Suzuki H. Distribution and pharmacological characterization of primate NK-1 and NK-3 tachykinin receptors in the central nervous system of the rhesus monkey. Br. J. Pharmacol. 2006, 147:316-323.
33. Norrholm S.D., Ressler K.J. Genetics of anxiety and trauma-related disorders. Neuroscience 2009, 164:272-287.
34. Petrovich G.D., Scicli A.P., Thompson R.F., Swanson L.W. Associative fear conditioning of enkephalin mRNA levels in central amygdalar neurons. Behav. Neurosci. 2000, 114:681-686.
35. Pinal C.S., Tobin A.J. Uniqueness and redundancy in GABA production. Perspect. Dev. Neurobiol. 1998, 5:109-118.
36. Poulin J.F., Bérubé P., Laforest S., Drolet G. Enkephalin knockdown in the central amygdala nucleus reduces unconditioned fear and anxiety. Eur. J. Neurosci. 2013, 37:1357-1367.
37. Rattiner L.M., Davis M., Ressler K.J. Differential regulation of brain-derived neurotrophic factor transcripts during the consolidation of fear learning. Learn. Mem. 2004, 11:727-731.
38. Rekling J.C. NK-3 receptor activation depolarizes and induces an after-depolarization in pyramidal neurons in gerbil cingulate cortex. Brain Res. Bull. 2004, 63:85-90.
39. Ressler K.J., Paschall G., Zhou X.L., Davis M. Regulation of synaptic plasticity genes during consolidation of fear conditioning. J.Neurosci. 2002, 22:7892-7902.
40. Ressler K.J., Mercer K.B., Bradley B., Jovanovic T., Mahan A., Kerley K., Norrholm S.D., Kilaru V., Smith A.K., Myers A.J., et al. Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature 2011, 470:492-497.
41. Siuciak J.A., McCarthy S.A., Martin A.N., Chapin D.S., Stock J., Nadeau D.M., Kantesaria S., Bryce-Pritt D., McLean S. Disruption of the neurokinin-3 receptor (NK3) in mice leads to cognitive deficits. Psychopharmacology (Berl.) 2007, 194:185-195.
42. Smith M.E., Flynn F.W. Distribution of Fos-like immunoreactivity within the rat brain following intraventricular injection of the selective NK(3) receptor agonist senktide. J.Comp. Neurol. 2000, 426:413-428.
43. Stevens J.S., Almli L.M., Fani N., Gutman D.A., Bradley B., Norrholm S.D., Reiser E., Ely T.D., Dhanani R., Glover E.M., et al. PACAP receptor gene polymorphism impacts fear responses in the amygdala and hippocampus. Proc. Natl. Acad. Sci. USA 2014, 111:3158-3163.
44. Sturn A., Quackenbush J., Trajanoski Z. Genesis: cluster analysis of microarray data. Bioinformatics 2002, 18:207-208.
45. Uddin M., Chang S.C., Zhang C., Ressler K., Mercer K.B., Galea S., Keyes K.M., McLaughlin K.A., Wildman D.E., Aiello A.E., Koenen K.C. Adcyap1r1 genotype, posttraumatic stress disorder, and depression among women exposed to childhood maltreatment. Depress. Anxiety 2013, 30:251-258.
46. Vermetten E., Lanius R.A. Biological and clinical framework for posttraumatic stress disorder. Handb. Clin. Neurol. 2012, 106:291-342.
47. Wilensky A.E., Schafe G.E., Kristensen M.P., LeDoux J.E. Rethinking the fear circuit: the central nucleus of the amygdala is required for the acquisition, consolidation, and expression of Pavlovian fear conditioning. J.Neurosci. 2006, 26:12387-12396.
48. Yip J., Chahl L.A. Localization of Fos-like immunoreactivity induced by the NK3 tachykinin receptor agonist, senktide, in the guinea-pig brain. Br. J. Pharmacol. 1997, 122:715-725.
49. Zlomuzica A., Dere E., Huston J.P., de Souza Silva M.A. NK(3) receptor agonism promotes episodic-like memory in mice. Neurobiol. Learn. Mem. 2008, 90:420-425.